• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Analysis of the risk factors for contrast-induced nephropathy in over-aged patients receiving coronary intervention.分析接受冠状动脉介入治疗的超龄患者对比剂肾病的危险因素。
Exp Biol Med (Maywood). 2018 Aug;243(12):970-975. doi: 10.1177/1535370218799973.
2
Age, glomerular filtration rate, ejection fraction, and the AGEF score predict contrast-induced nephropathy in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention.年龄、肾小球滤过率、射血分数和AGEF评分可预测接受直接经皮冠状动脉介入治疗的急性心肌梗死患者的造影剂肾病。
Catheter Cardiovasc Interv. 2013 Nov 15;82(6):878-85. doi: 10.1002/ccd.25023. Epub 2013 Jun 27.
3
Contrast-Induced Nephropathy After Percutaneous Coronary Intervention for Chronic Total Occlusion Versus Non-Occlusive Coronary Artery Disease.经皮冠状动脉介入治疗慢性完全闭塞病变与非闭塞性冠状动脉疾病对比所致对比剂肾病。
Am J Cardiol. 2018 Dec 1;122(11):1837-1842. doi: 10.1016/j.amjcard.2018.08.022. Epub 2018 Sep 8.
4
Elevated homocysteine and the risk of contrast-induced nephropathy: a cohort study.高同型半胱氨酸血症与对比剂肾病风险:一项队列研究
Angiology. 2015 Apr;66(4):333-8. doi: 10.1177/0003319714533401. Epub 2014 May 15.
5
Combined impact of chronic kidney disease and contrast-induced nephropathy on long-term outcomes in patients with ST-segment elevation acute myocardial infarction who undergo primary percutaneous coronary intervention.慢性肾脏病和造影剂肾病对接受直接经皮冠状动脉介入治疗的ST段抬高型急性心肌梗死患者长期预后的联合影响。
Heart Vessels. 2017 Jan;32(1):22-29. doi: 10.1007/s00380-016-0836-8. Epub 2016 Apr 22.
6
Relation of uric acid and contrast-induced nephropathy in patients undergoing primary percutaneous coronary intervention in the ED.急诊经皮冠状动脉介入治疗患者尿酸与对比剂诱导肾病的关系。
Am J Emerg Med. 2014 Feb;32(2):119-23. doi: 10.1016/j.ajem.2013.10.011. Epub 2013 Oct 11.
7
Impact of vascular access on the development of contrast induced nephropathy in patients undergoing coronary angiography and/or percutaneous coronary intervention.血管通路对行冠状动脉造影和/或经皮冠状动脉介入治疗的患者对比剂肾病发展的影响。
Int J Cardiol. 2019 Jan 15;275:48-52. doi: 10.1016/j.ijcard.2018.08.026. Epub 2018 Aug 10.
8
Efficacy of nicorandil treatment for prevention of contrast-induced nephropathy in high-risk patients undergoing cardiac catheterization: A prospective randomized controlled trial.尼可地尔治疗对预防接受心脏导管插入术的高危患者造影剂肾病的疗效:一项前瞻性随机对照试验。
Cardiol J. 2017;24(5):502-507. doi: 10.5603/CJ.a2017.0028. Epub 2017 Mar 10.
9
Insulin Resistance Increases the Risk of Contrast-Induced Nephropathy in Patients Undergoing Elective Coronary Intervention.胰岛素抵抗增加择期冠状动脉介入治疗患者发生造影剂肾病的风险。
Angiology. 2016 Feb;67(2):139-45. doi: 10.1177/0003319715578997. Epub 2015 Apr 5.
10
Drug Effects and Clinical Investigations for Contrast-Induced Nephropathy After Coronary Angiography or Percutaneous Coronary Intervention in Patients With Diabetes.糖尿病患者冠状动脉造影或经皮冠状动脉介入术后对比剂肾病的药物疗效及临床研究
Am J Ther. 2017 Jul/Aug;24(4):e423-e430. doi: 10.1097/MJT.0000000000000325.

引用本文的文献

1
Mehran Mehran2 pre-procedure: which score better predicts risk of contrast-induced acute kidney injury in patients with acute coronary syndrome?梅兰 梅兰2术前:哪种评分能更好地预测急性冠状动脉综合征患者发生对比剂诱导的急性肾损伤的风险?
PeerJ. 2025 Apr 15;13:e19166. doi: 10.7717/peerj.19166. eCollection 2025.
2
Association between the triglyceride-glucose index and contrast-induced nephropathy in chronic total occlusion patients undergoing percutaneous coronary intervention.经皮冠状动脉介入治疗的慢性完全闭塞患者中甘油三酯-葡萄糖指数与对比剂肾病的关联
BMC Cardiovasc Disord. 2025 Jan 20;25(1):31. doi: 10.1186/s12872-025-04474-5.
3
Post-contrast acute kidney injury in the super-elder patients: a CT-scan perspective.超高龄患者对比剂后急性肾损伤:CT扫描视角
Jpn J Radiol. 2025 Feb;43(2):247-254. doi: 10.1007/s11604-024-01656-7. Epub 2024 Sep 12.
4
Association between Pan-Immune-Inflammation Value and Contrast-Induced Nephropathy with Coronary Angiography.全免疫炎症值与冠状动脉造影对比剂肾病的相关性。
Medicina (Kaunas). 2024 Jun 20;60(6):1012. doi: 10.3390/medicina60061012.
5
Prognostic Nutritional Index Combined with Triglyceride-Glucose Index to Contrast a Nomogram for Predicting Contrast-Induced Kidney Injury in Type 2 Diabetes Mellitus Patients with Acute Coronary Syndrome After Percutaneous Coronary Intervention.预后营养指数联合甘油三酯-葡萄糖指数构建列线图预测经皮冠状动脉介入治疗的急性冠状动脉综合征合并 2 型糖尿病患者对比剂肾病
Clin Interv Aging. 2023 Oct 3;18:1663-1673. doi: 10.2147/CIA.S429957. eCollection 2023.
6
A Predictive Model for Contrast-Induced Acute Kidney Injury After Percutaneous Coronary Intervention in Elderly Patients with ST-Segment Elevation Myocardial Infarction.预测老年 ST 段抬高型心肌梗死患者经皮冠状动脉介入治疗后对比剂诱导急性肾损伤的模型。
Clin Interv Aging. 2023 Mar 22;18:453-465. doi: 10.2147/CIA.S402408. eCollection 2023.
7
A Clinical Nomogram Based on the Triglyceride-Glucose Index to Predict Contrast-Induced Acute Kidney Injury after Percutaneous Intervention in Patients with Acute Coronary Syndrome with Diabetes Mellitus.基于三酰甘油-葡萄糖指数的临床列线图预测糖尿病急性冠脉综合征患者经皮冠状动脉介入治疗后对比剂诱导的急性肾损伤。
Cardiovasc Ther. 2022 Oct 27;2022:5443880. doi: 10.1155/2022/5443880. eCollection 2022.
8
Risk factors of contrast-induced nephropathy after percutaneous coronary intervention: a retrospective analysis.经皮冠状动脉介入治疗后对比剂肾病的危险因素:一项回顾性分析
J Int Med Res. 2021 Apr;49(4):3000605211005972. doi: 10.1177/03000605211005972.
9
Fluid Stewardship of Maintenance Intravenous Fluids.维持性静脉输液的液体管理。
J Pharm Pract. 2022 Oct;35(5):769-782. doi: 10.1177/08971900211008261. Epub 2021 Apr 8.
10
Dietary restriction for prevention of contrast-induced acute kidney injury in patients undergoing percutaneous coronary angiography: a randomized controlled trial.饮食限制预防经皮冠状动脉造影患者对比剂诱导急性肾损伤:一项随机对照试验。
Sci Rep. 2020 Mar 23;10(1):5202. doi: 10.1038/s41598-020-61895-2.

本文引用的文献

1
[2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation.].[2017年欧洲心脏病学会ST段抬高型急性心肌梗死患者管理指南。]
Kardiol Pol. 2018;76(2):229-313. doi: 10.5603/KP.2018.0041.
2
Early coronary angiography and percutaneous coronary intervention are associated with improved outcomes after out of hospital cardiac arrest.院外心脏骤停后早期进行冠状动脉造影和经皮冠状动脉介入治疗与改善预后相关。
Resuscitation. 2018 Feb;123:15-21. doi: 10.1016/j.resuscitation.2017.12.004. Epub 2017 Dec 6.
3
2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation.2017年欧洲心脏病学会(ESC)ST段抬高型急性心肌梗死患者管理指南。
Rev Esp Cardiol (Engl Ed). 2017 Dec;70(12):1082. doi: 10.1016/j.rec.2017.11.010.
4
Risk Factors for Coronary Artery Disease: Historical Perspectives.冠状动脉疾病的风险因素:历史视角
Heart Views. 2017 Jul-Sep;18(3):109-114. doi: 10.4103/HEARTVIEWS.HEARTVIEWS_106_17.
5
Feasibility of coronary angiography and percutaneous coronary intervention after transcatheter aortic valve replacement using a Medtronic™ self-expandable bioprosthetic valve.使用美敦力™自膨胀生物瓣膜进行经导管主动脉瓣置换术后冠状动脉造影和经皮冠状动脉介入治疗的可行性
Catheter Cardiovasc Interv. 2018 Jun;91(7):1339-1344. doi: 10.1002/ccd.27346. Epub 2017 Oct 8.
6
Incidence of Contrast-Induced Nephropathy in Patients with Multiple Myeloma Undergoing Contrast-Enhanced Procedures.接受造影增强检查的多发性骨髓瘤患者中对比剂肾病的发生率
Pathol Oncol Res. 2018 Oct;24(4):915-919. doi: 10.1007/s12253-017-0300-9. Epub 2017 Sep 13.
7
Prevalence and associations of microalbuminuria in proteinuria-negative patients with type 2 diabetes in two regional hospitals in Cameroon: a cross-sectional study.喀麦隆两家地区医院中2型糖尿病蛋白尿阴性患者微量白蛋白尿的患病率及相关性:一项横断面研究
BMC Res Notes. 2017 Sep 12;10(1):477. doi: 10.1186/s13104-017-2804-5.
8
Hypertensive Kidney Injury and the Progression of Chronic Kidney Disease.高血压肾损伤与慢性肾脏病的进展
Hypertension. 2017 Oct;70(4):687-694. doi: 10.1161/HYPERTENSIONAHA.117.08314. Epub 2017 Jul 31.
9
Role of Routine Follow-up Coronary Angiography After Percutaneous Coronary Intervention - Systematic Review and Meta-Analysis.经皮冠状动脉介入治疗后常规随访冠状动脉造影的作用:系统评价和荟萃分析。
Circ J. 2017 Dec 25;82(1):203-210. doi: 10.1253/circj.CJ-17-0410. Epub 2017 Jul 29.
10
Retrospective Comparison of Estimated GFR using 2006 MDRD, 2009 CKD-EPI and Cockcroft-Gault with 24 Hour Urine Creatinine Clearance.使用2006年MDRD公式、2009年CKD-EPI公式和Cockcroft-Gault公式估算的肾小球滤过率与24小时尿肌酐清除率的回顾性比较
J Clin Diagn Res. 2017 May;11(5):BC09-BC12. doi: 10.7860/JCDR/2017/25124.9889. Epub 2017 May 1.

分析接受冠状动脉介入治疗的超龄患者对比剂肾病的危险因素。

Analysis of the risk factors for contrast-induced nephropathy in over-aged patients receiving coronary intervention.

机构信息

Department of Cardiology, Shanghai Tong Ren Hospital, Shanghai 200336, China.

出版信息

Exp Biol Med (Maywood). 2018 Aug;243(12):970-975. doi: 10.1177/1535370218799973.

DOI:10.1177/1535370218799973
PMID:30299175
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6180409/
Abstract

Contrast-induced nephropathy has been the common cause of hospital-acquired acute kidney injury in the elderly patients. This study aimed to analyze the risk factors for contrast-induced nephropathy in over-aged patients undergoing coronary angiography or percutaneous coronary intervention. A total of 470 over-aged patients (≥80 years old) were judged as the contrast-induced nephropathy group ( n = 46) and non-contrast-induced nephropathy group ( n = 424) according to the postoperative 48-h serum creatinine levels. The patients' clinical information such as hypertension grade, number and degree of coronary artery stenosis, and death rate was compared. The risk factors for contrast-induced nephropathy were also analyzed. The hypertension grade in the contrast-induced nephropathy group was significantly higher than that in the non-contrast-induced nephropathy group ( P = 0.004). The degree of coronary artery stenosis was significantly more in the contrast-induced nephropathy group compared with the non-contrast-induced nephropathy group ( P = 0.003). The death rate of the contrast-induced nephropathy group (15.8%) was significantly higher than that of the non-contrast-induced nephropathy group (0.6%; P = 0.000). The percentage of patients with abnormal urine microalbumin was significantly bigger in the contrast-induced nephropathy group (62.5%) when comparing to the non-contrast-induced nephropathy group (23.6%; P = 0.00). Besides, there was also significant difference in the emergency/selective operation between the contrast-induced nephropathy group and non-contrast-induced nephropathy group ( P = 0.001). Further, hypertension grade ( P = 0.019), emergency/selective operation ( P = 0.025), degree of coronary artery stenosis ( P = 0.038), eGFR ( P = 0.034), and urine microalbumin ( P = 0.005) were the risk factors for contrast-induced nephropathy. Hypertension grade, emergency/selective operation, degree of coronary artery stenosis, eGFR, and urine microalbumin were the risk factors for contrast-induced nephropathy in over-aged patients receiving coronary angiography and percutaneous coronary intervention, providing guidance for the clinical prevention of contrast-induced nephropathy. Impact statement In this work, we evaluated the risk factors for contrast-induced nephropathy (CIN) in over-aged patients receiving coronary angiography (CAG) and percutaneous coronary intervention (PCI). We found that hypertension grade, emergency/selective operation, degree of coronary artery stenosis, eGFR, and urine microalbumin were the risk factors for CIN in over-aged patients receiving CAG and PCI. This study provides guidance for the clinical prevention of CIN in over-aged patients undergoing coronary intervention, highlighting that a perioperative comprehensive management strategy is needed to improve the prognosis.

摘要

对比剂肾病已成为老年患者医院获得性急性肾损伤的常见原因。本研究旨在分析冠状动脉造影或经皮冠状动脉介入治疗中超龄患者发生对比剂肾病的危险因素。根据术后 48 小时血清肌酐水平,将 470 名超龄患者(≥80 岁)判断为对比剂肾病组(n=46)和非对比剂肾病组(n=424)。比较患者的临床资料,如高血压分级、冠状动脉狭窄程度和程度、数量和死亡率。还分析了对比剂肾病的危险因素。对比剂肾病组的高血压分级明显高于非对比剂肾病组(P=0.004)。对比剂肾病组的冠状动脉狭窄程度明显大于非对比剂肾病组(P=0.003)。对比剂肾病组的死亡率(15.8%)明显高于非对比剂肾病组(0.6%;P=0.000)。对比剂肾病组(62.5%)异常尿微量白蛋白的患者比例明显大于非对比剂肾病组(23.6%;P=0.00)。此外,在对比剂肾病组和非对比剂肾病组之间,急诊/选择性手术之间也存在显著差异(P=0.001)。此外,高血压分级(P=0.019)、急诊/选择性手术(P=0.025)、冠状动脉狭窄程度(P=0.038)、eGFR(P=0.034)和尿微量白蛋白(P=0.005)是对比剂肾病的危险因素。高血压分级、急诊/选择性手术、冠状动脉狭窄程度、eGFR 和尿微量白蛋白是接受冠状动脉造影和经皮冠状动脉介入治疗的超龄患者发生对比剂肾病的危险因素,为临床预防对比剂肾病提供了指导。 影响声明 在这项工作中,我们评估了接受冠状动脉造影(CAG)和经皮冠状动脉介入治疗(PCI)的超龄患者发生对比剂肾病(CIN)的危险因素。我们发现,高血压分级、急诊/选择性手术、冠状动脉狭窄程度、eGFR 和尿微量白蛋白是接受 CAG 和 PCI 的超龄患者发生 CIN 的危险因素。这项研究为接受冠状动脉介入治疗的超龄患者的 CIN 临床预防提供了指导,强调需要综合管理策略来改善预后。